ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

NAVB Navidea Biopharmaceuticals Inc

0.0779
0.00 (0.00%)
Fuera de horario
Última actualización: 19:00:00
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Navidea Biopharmaceuticals Inc NAVB AMEX Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 0.0779 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.0779 0.0779
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
21/12/202314:32EDGAR2Form SC 13D/A - General statement of acquisition of..
05/12/202317:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/12/202310:49EDGAR2Form 8-K - Current report
16/11/202315:55EDGAR2Form 8-K - Current report
23/10/202312:56EDGAR2Form 25-NSE - Notification filed by national security..
05/10/202320:01BWNavidea Biopharmaceuticals, Inc. Announces NYSE American’s..
05/10/202315:21EDGAR2Form DEF 14A - Other definitive proxy statements
15/9/202314:42EDGAR2Form PRE 14A - Other preliminary proxy statements
10/9/202323:15EDGAR2Form EFFECT - Notice of Effectiveness
15/8/202316:53EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/8/202315:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202308:29BWNavidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing..
08/8/202315:23EDGAR2Form 8-K - Current report
31/7/202308:32BWNavidea Biopharmaceuticals, Inc. Presses Ahead, Embraces..
28/7/202319:23BWNavidea Biopharmaceuticals, Inc. Announces NYSE American Has..
28/7/202316:10EDGAR2Form 8-K - Current report
27/7/202316:20BWNavidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as..
17/7/202317:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/7/202317:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/7/202316:27EDGAR2Form 8-K - Current report
13/7/202316:09BWNavidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to..
06/7/202315:39EDGAR2Form 8-K - Current report
03/7/202316:30EDGAR2Form DEF 14A - Other definitive proxy statements
03/7/202315:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/6/202315:01EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/6/202309:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/6/202308:16BWNavidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer..
16/6/202315:54BWNavidea Biopharmaceuticals, Inc. Announces Distribution of..
16/6/202312:52BWNavidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash..
07/6/202315:00BWNavidea Biopharmaceuticals, Inc. Reports First Quarter 2023..
02/6/202316:54BWNavidea Biopharmaceuticals, Inc. Receives NYSE American..
01/6/202316:53BWNavidea Biopharmaceuticals, Inc. Welcomes Jill Bieker..
22/5/202317:30BWNavidea Biopharmaceuticals, Inc. Investors Purchase $1.1..
11/5/202316:35BWNavidea Biopharmaceuticals, Inc. Promotes Michael Sherman..
08/5/202315:12BWNavidea Biopharmaceuticals, Inc. Drives Strategy Forward,..

Su Consulta Reciente

Delayed Upgrade Clock